{"nct_id":"NCT01385657","title":"Safety and Tolerability of Dupilumab in Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","status_verified_date":"2020-02","start_date":"2011-07-31","start_date_type":"ACTUAL","primary_completion_date":"2012-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2012-03-31","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}